上海招聘Feasibility Strategic Lead

Feasibility Strategic Lead

精鼎医药研究开发（上海）有限公司

公司规模：10000人以上
公司性质：外资(欧美)
公司行业：制药/生物工程

职位信息

发布日期：2019-01-21
工作地点：上海-浦东新区
招聘人数：若干人
工作经验：无工作经验
学历要求：招若干人
语言要求：不限
职位月薪：20-30万/年
职位类别：临床研究员

职位描述

The Feasibility & Strategy Leader (FSL) acts as a key contributor to the proposal team to support PAREXEL in winning new business. Working independently with limited supervision from management, the FSL is responsible to deliver, in collaboration with Patient Recruitment Strategy (PRS) and Site Alliance (SA) groups, an optimized integrated strategic approach to target the right countries, right sites, and right patients for Request for Proposals (RFPs) on all types and phases of studies. The FSL must demonstrate good communication and time management skills resulting in the completion of all deliverables within required timelines meeting proposal team needs and departmental quality standards. Good analytical and writing skills are a pre-requisite to the job to allow FSL to fully adopt a consistent data-driven approach to feasibility and deliver clear, concise, selling proposal texts.

Job Qualifications : ? Strong analytical skills applied to business needs;? Excellent interpersonal, presentation, verbal and written communication;? Demonstrated leadership capabilities, and ability to influence others;? Problem-solving skills allowing Client focused approach to work;? Ability to multitask to tight timelines prioritizing workload and maintaining high quality standards? Willingness to work in a matrix environment, work independently and part of a dynamic team and in a decentralized reporting model (as applicable)

职能类别：临床研究员

公司介绍

精鼎医药（Parexel International）是全球领先的药物研究合同委托机构（CRO），总部位于美国生物医药圣地马萨诸塞州的波士顿附近，在世界各地拥有71个办事处，约17,600 名员工，为超过100个国家的客户提供服务。

精鼎医药成立于1982年，在三十多年的历程中，一直致力于发展成为全球生物制药和医疗器械行业首屈一指的新型医学疗法开发和商业化服务供应商，并且取得了卓越成果。目前，我们能够提供全世界CRO领域全面的新药临床阶段研发服务，服务内容包括新药开发策略的拟定与计划、国际临床试验规划执行及整合、临床试验的监测、临床试验数据处理、临床研究统计分析、临床试验总结及统计报告、临床试验稽核服务、临床试验供应和物流服务、临床电子数据采集、临床医学信息管理系统、新药查验登记事务和国际临床试验相关法规咨询等。

将我们的全球法规监管专业经验、I-IV期临床研究服务、整合的电子化临床技术能力和商业化服务结合在一起的一体化解决方案，可帮助我们的客户更加顺畅、经济和高效的推动整个研发历程。

联系方式